How much funding has Nordic Bioscience raised?

Nordic Bioscience has raised $100.0M in total funding, most recently a Private Equity round.

Who are Nordic Bioscience's investors?

Nordic Bioscience's investors include KKR.

When was Nordic Bioscience founded?

Nordic Bioscience was founded in 1996.

Where is Nordic Bioscience headquartered?

Nordic Bioscience is headquartered in Herlev, Denmark.

What industry is Nordic Bioscience in?

Nordic Bioscience operates in Biotech, Life Sciences.

How many employees does Nordic Bioscience have?

Nordic Bioscience has 51-200 employees.

Nordic Bioscience

Advancing precision medicine through biomarker science

Herlev, Denmark · Founded 1996 · $100.0M raised

Biotech

Life Sciences

Headquarters: Herlev
Employees: 51–200
Founded: 1996
Business Model: B2B

Website: nordicbioscience.com
Total Funding: $100.0M
Last Round: $100.0M Private EquityMar 2021
Rounds: 1

About

Nordic Bioscience is a Denmark-based, research-driven biomarker company specializing in the development and commercialization of extracellular matrix (ECM) biomarkers for pharmaceutical and diagnostics partners. Using its proprietary ProteinFingerPrint technology, the company measures specific protein fragments — particularly collagen and ECM degradation products — to support drug development across a wide range of disease areas including rheumatology, hepatic fibrosis, oncology, cardiovascular, respiratory, kidney, and neurological diseases. Nordic Bioscience offers laboratory services, kit-in-a-box biomarker products, and translational research models. It has contributed to over 750 scientific publications and counts major pharma companies among its partners. The company is headquartered in Herlev, Denmark, and was founded in 1996.

Summary

Nordic Bioscience is a Biotech company based in Herlev, Denmark, founded in 1996. It has raised $100.0M in total across 1 round, most recently a $100.0M Private Equity round in Mar 2021. Investors include KKR.